Why the study?
Arterial hypertension remains a leading cause of cardiovascular morbidity and mortality worldwide, with target blood pressure levels remaining unachieved in a substantial number of patients.
Does the combination of valsartan and indapamide improve blood pressure control and cardiovascular outcomes in patients with arterial hypertension?
Does the combination of valsartan and indapamide improve blood pressure control and cardiovascular outcomes in patients with arterial hypertension?
The fixed-dose combination of valsartan and indapamide is a highly effective, metabolically neutral, and well-tolerated option for hypertension management that aligns with European guidelines.
Offers metabolically neutral option for hypertension; leaves open prospective outcome trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Daniel Lovrić (2025) conducted a review in Arterial hypertension. Valsartan and indapamide combination was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: